MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1039/d6md00430j

Медицинская библиотека · RSC medicinal chemistry · 2026

Development of atropisomeric 5N-sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase.

Tabata Hidetsugu, Miyata Yoshiki, Kusakabe Yoshio, Takahashi Hideyo, Natsugari Hideaki, Oshitari Tetsuta

СтатьяПеревод в очереди

Аннотация

Novel 5N-sulfonyl-1,5-benzodiazepin-2-one derivatives (2b, d) with strong inhibition of neutrophil elastase have been developed. The atropisomers of 2d, based on the rotation of the two interlocking sp2-sp2 (Ar-N) axes [(aR, aR) and (aS, aS)], were stably isolated at room temperature by HPLC using a chiral column. A significant difference was observed in the inhibitory activity between the atropisomers [(+)-2d, (-)-2d, and (±)-2d], and the eutomer was revealed to be (+)-2d. The X-ray analysis revealed that the configuration of the eutomer (+)-2d was (aR, aR). The eutomer exhibited approximately 10-fold higher inhibitory activity than the currently used lead compound sivelestat (ONO-0546) (1), indicating its potential as a treatment for acute lung injury. Docking studies with target proteins supported our hypothesis of high activity.

Для цитирования: Tabata Hidetsugu, Miyata Yoshiki, Kusakabe Yoshio, Takahashi Hideyo, Natsugari Hideaki, Oshitari Tetsuta. Development of atropisomeric 5N-sulfonyl-1,5-benzodiazepin-2-ones with high inhibitory activity against neutrophil elastase.. RSC medicinal chemistry. 2026. DOI: 10.1039/d6md00430j.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.